PortfoliosLab logoPortfoliosLab logo
AMLX vs. SIFY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMLX vs. SIFY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amylyx Pharmaceuticals, Inc. (AMLX) and Sify Technologies Limited (SIFY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMLX achieves a 68.13% return, which is significantly higher than SIFY's 20.10% return.


AMLX

1D
-2.12%
1M
11.17%
6M
42.13%
YTD
68.13%
1Y
163.25%
3Y*
-4.58%
5Y*
10Y*
ALL TIME*
-0.73%

SIFY

1D
0.41%
1M
-4.44%
6M
-0.61%
YTD
20.10%
1Y
119.82%
3Y*
3.67%
5Y*
-6.03%
10Y*
8.87%
ALL TIME*
9.87%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$41.59M$31.68M$25.94M
$573.20K$597.42K$1.08M

AMLX vs. SIFY - Yearly Performance Comparison


2026 (YTD)2025202420232022
AMLX
Amylyx Pharmaceuticals, Inc.
68.13%219.58%-74.32%-60.16%75.95%
SIFY
Sify Technologies Limited
20.10%326.22%-74.44%61.96%-62.12%

Correlation

The correlation between AMLX and SIFY is 0.12, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.12

Correlation (3Y)
Balances recent behavior with more history.

0.11

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2022

0.14

Fundamentals

Market Cap

AMLX:

$2.26B

SIFY:

$1.06B

EPS

AMLX:

-$1.51

SIFY:

-₹18.77

PB Ratio

AMLX:

8.22

SIFY:

6.67

Total Revenue (TTM)

AMLX:

$0.00

SIFY:

₹45.06B

Gross Profit (TTM)

AMLX:

-$20.10M

SIFY:

₹16.11B

EBITDA (TTM)

AMLX:

-$150.30M

SIFY:

₹10.33B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMLX vs. SIFY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

AMLX
AMLX Risk / Return Rank: 9393
Overall Rank
AMLX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9393
Sortino Ratio Rank
AMLX Omega Ratio Rank: 8989
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9595
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9292
Martin Ratio Rank

SIFY
SIFY Risk / Return Rank: 8484
Overall Rank
SIFY Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
SIFY Sortino Ratio Rank: 8383
Sortino Ratio Rank
SIFY Omega Ratio Rank: 8282
Omega Ratio Rank
SIFY Calmar Ratio Rank: 8787
Calmar Ratio Rank
SIFY Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

AMLX vs. SIFY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amylyx Pharmaceuticals, Inc. (AMLX) and Sify Technologies Limited (SIFY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMLXSIFYDifference
Sharpe ratioReturn per unit of total volatility

+0.95

Sortino ratioReturn per unit of downside risk

+0.89

Omega ratioGain probability vs. loss probability

1.35

1.28

+0.07

Calmar ratioReturn relative to maximum drawdown

5.03

2.98

+2.05

Martin ratioReturn relative to average drawdown

10.76

6.16

+4.61

AMLX vs. SIFY - Sharpe Ratio Comparison

The current AMLX Sharpe Ratio is 2.51, which is higher than the SIFY Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of AMLX and SIFY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMLX vs. SIFY - Drawdown Comparison

The maximum AMLX drawdown since its inception was -96.04%, roughly equal to the maximum SIFY drawdown of -99.59%. Use the drawdown chart below to compare losses from any high point for AMLX and SIFY.


Loading charts...

Drawdown Indicators


AMLXSIFYDifference

Max Drawdown

Largest peak-to-trough decline

-96.04%

-99.59%

+3.55%

Max Drawdown (1Y)

Largest decline over 1 year

-30.61%

-40.23%

+9.62%

Max Drawdown (3Y)

Largest decline over 3 years

-92.80%

-85.65%

-7.15%

Max Drawdown (5Y)

Largest decline over 5 years

-91.98%

Max Drawdown (10Y)

Largest decline over 10 years

-94.34%

Current Drawdown

Current decline from peak

-50.38%

-56.81%

+6.43%

Average Drawdown

Average peak-to-trough decline

-59.30%

-79.15%

+19.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.27%

19.43%

-5.16%

Volatility

AMLX vs. SIFY - Volatility Comparison

Amylyx Pharmaceuticals, Inc. (AMLX) and Sify Technologies Limited (SIFY) have volatilities of 15.49% and 15.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMLXSIFYDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.49%

15.82%

-0.33%

Volatility (6M)

Calculated over the trailing 6-month period

39.64%

43.36%

-3.72%

Volatility (1Y)

Calculated over the trailing 1-year period

61.22%

76.79%

-15.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

90.71%

88.49%

+2.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

90.71%

84.64%

+6.07%

Dividends

AMLX vs. SIFY - Dividend Comparison

Neither AMLX nor SIFY has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMLX
Amylyx Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SIFY
Sify Technologies Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%0.96%0.83%136.99%101.52%

Financials

AMLX vs. SIFY - Financials Comparison

This section allows you to compare key financial metrics between Amylyx Pharmaceuticals, Inc. and Sify Technologies Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


AMLX and SIFY have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SIFY has higher volatility (15.82%) compared to AMLX (15.49%). In terms of maximum drawdown, AMLX dropped -96.04% vs SIFY's -99.59%.

AMLX currently has the higher Sharpe Ratio (2.51 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMLX and SIFY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer